With an ambition to always simplify and improve access to high quality medicine our success comes from developing sustainable solutions and partnerships in mature tender and key accounts driven markets in Europe with a 100% focus on Generics.
Today we deliver a high quality, efficient and sustainable healthcare – tomorrow we earn your trust.
Xiromed in Europe today:
Our geographical coverage in Europe spans across north EU, Sweden, Denmark, Norway, Iceland, Finland, UK, The Netherlands and Germany (internationally we are also present in the US and with our sister organization Exeltis we cover 50+ countries).
Xiromed and its branded sister company Exeltis focusing on women health are divisions of Chemo Group.